acuteadditionadenocarcinomaadjuvantadolescentsadultsadvancedalkamlamonganalysisannualanotherarticleascoassessmentassociatedautologousbasedbetterbevacizumabbiologybiomarkerbiopsybladderbrafbrainbrca1breastcancercancerscarcinomacardiaccarecellchemotherapychildhoodchildrencoloncolorectalcombinationdatadecisiondetectiondiagnoseddiffusediscussiondiseasedisparitiesdondosedurvalumabearlyefficacyegfrendendometrialevolutionfinancialfirstfollicularfollowfollowingfuturegastricgermlineheadhematopoieticher2highhodgkinhormonehoursiiiimagingimmuneimmunotherapyimpactimplicationsimportanceimproveimprovesinducedinhibitioninhibitorinsightsinvasivelargelateleukemialifelikelinelocallylonglowlunglymphoblasticlymphomalymphomasmaintenancemanagementmedicalmedicaremeetingmelanomametastasesmetastaticminimalmolecularmortalitymrdmultimultiplemutantmutationmutationsmyeloidmyelomanecknegativeneoadjuvantnivolumabnovelnsclcolderoptionsoutcomeoutcomesovarianpancreaticpatientpatientspediatricpembrolizumabphaseplatinumpluspositiveprimaryprimeprognosticpromiseprostatequalityquestionracialradiationradiotherapyrarereadyreceivingreceptorrectalrecurrencerecurrentrefractoryrelapsedrelatedresearchresidualresponseresultsriskrituximabrolesafetyscreeningsecondsettingsinglesmallsmokingstagestemstudysurgerysurvivalsurvivorstamoxifentermtestingtherapeutictherapytimetoxicitytransplanttransplantationtrastuzumabtreatedtreatmenttrialtrialstumortumorsuseusingvalueversuswomen